Burd L, Fisher W, Kerbeshian J. 1987. A prevalence study of pervasive developmental disorders in North Dakota. J Am Acad Child Adolesc Psychiatry 26(5):700-3.


California Department of Developmental Services. 2003. Autistic Spectrum Disorders. Changes in the California Caseload. An Update: 1999 Through 2002. Sacramento, CA: California Health and Human Services Agency.

California Health and Human Services Agency, Department of Developmental Services. 1999. Changes in the Population of Persons with Autism and Pervasive Developmental Disorders in California’s Developmental Services System: 1987 Through 1998.

Carbone KM, Rubin SA, Pletnikov M. 2002. Borna disease virus (BDV)-induced model of autism: application to vaccine safety test design. Mol Psychiatry 7 (Suppl 2):S36-7.

Casanova MF, Buxhoeveden DP, Switala AE, Roy E. 2002. Neuronal density and architecture (Gray Level Index) in the brains of autistic patients. J Child Neurol 17(7):515-21.

CDC (Centers for Disease Control and Prevention). 1991. Hepatitis B Virus: A Comprehensive Strategy for Eliminating Transmission in the United States Through Universal Childhood Vaccination: Recommendations of the Immunization Practices Advisory Committee (ACIP). Morb Mortal Wkly Rep. 40(RR-13):1-19 .

CDC. 1997. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC. Morb Mortal Wkly Rep 46(RR–11):1-20.

CDC. 1998. Measles, mumps, and rubella—vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 47(RR–8):1-57.

CDC. 1999a. Autism spectrum disorders among children. [Online] Available: http://www.cdc.gov/ncbddd/fact/tasdfs.htm [accessed 2001].

CDC. 1999b. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. Morb Mortal Wkly Rep 48(26):563-5.

CDC. 2000. Measles—United States, 1999. Morb Mortal Wkly Rep 49(25):557-60.

CDC. 2002. Estimated vaccination coverage with individual vaccines by 3 months of age by state and immunization action plan area- US, National Immunization Survey Q1/2001-Q4/2001. Available [online]: http://www.cdc.gov/nip/coverage/NIS/01/TAB4-3months_iap.htm [accessed December, 2002].

CDC. 2003a. ACIP expands recommendation for vaccinating children in the 2004-05 flu season. [Online] Available at: www.cdc.gov/flu/professionals/acip/acipchild0405.htm.

CDC. 2003b. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 52(RR-8):1-35.

CDC. 2004. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 53:1-40.

Chen RT. 1994. Special methodological issues in pharmacoepidemiology studies of vaccine safety. Strom BL, ed. Pharmacoepidemiology. 2nd ed. New York: Wiley.

Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN. 1999. Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14(6):388-94.

Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK. 1999. Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr 134(5):607-13.

Cook EH Jr, Perry BD, Dawson G, Wainwright MS, Leventhal BL. 1993. Receptor inhibition by immunoglobulins: specific inhibition by autistic children, their relatives, and control subjects. J Autism Dev Disord 23(1):67-78.

Courchesne E, Carper R, Akshoomoff N. 2003. Evidence of brain overgrowth in the first year of life in autism. JAMA 290(3):337-44.

Croen LA, Grether JK, Hoogstrate J, Selvin S. 2002. The changing prevalence of autism in California. J Autism Dev Disord 32(3):207-15.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement